Monsenso Past Earnings Performance
Past criteria checks 0/6
Monsenso's earnings have been declining at an average annual rate of -23.5%, while the Healthcare Services industry saw earnings growing at 6.7% annually. Revenues have been declining at an average rate of 3% per year.
Key information
-23.5%
Earnings growth rate
35.2%
EPS growth rate
| Healthcare Services Industry Growth | 16.1% |
| Revenue growth rate | -3.0% |
| Return on equity | -49.3% |
| Net Margin | -55.7% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Monsenso makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 10 | -5 | 5 | 6 |
| 30 Sep 23 | 9 | -6 | 5 | 6 |
| 30 Jun 23 | 8 | -6 | 5 | 6 |
| 31 Mar 23 | 7 | -7 | 6 | 5 |
| 31 Dec 22 | 6 | -8 | 7 | 5 |
| 30 Sep 22 | 6 | -8 | 8 | 4 |
| 30 Jun 22 | 6 | -9 | 9 | 4 |
| 31 Mar 22 | 7 | -8 | 9 | 4 |
| 31 Dec 21 | 7 | -8 | 9 | 4 |
| 30 Sep 21 | 8 | -7 | 9 | 5 |
| 30 Jun 21 | 10 | -5 | 9 | 5 |
| 31 Mar 21 | 9 | -5 | 8 | 5 |
| 31 Dec 20 | 9 | -5 | 7 | 4 |
| 30 Sep 20 | 8 | -4 | 5 | 5 |
| 30 Jun 20 | 8 | -3 | 2 | 5 |
| 31 Mar 20 | 8 | -2 | 3 | 4 |
| 31 Dec 19 | 9 | 0 | 3 | 3 |
| 31 Dec 18 | 9 | -2 | 7 | 0 |
| 31 Dec 17 | 9 | -3 | 10 | 0 |
| 31 Dec 16 | 5 | -3 | 6 | 0 |
| 31 Dec 15 | 1 | -1 | 2 | 0 |
Quality Earnings: MONSO is currently unprofitable.
Growing Profit Margin: MONSO is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MONSO is unprofitable, and losses have increased over the past 5 years at a rate of 23.5% per year.
Accelerating Growth: Unable to compare MONSO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MONSO is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (8.6%).
Return on Equity
High ROE: MONSO has a negative Return on Equity (-49.27%), as it is currently unprofitable.